Click for best price
Flu RNA Vaccines Market Size, Share 2022
The major advantage of Flu RNA Vaccines is that scientist need not to use the live cells for the vaccine preparation as such the RNA can be produced in the laboratory from a DNA template using readily available materials which can be a easy and fast weapon to fight against the new outbreaks and the existing infectious diseases.
This report contains market size and forecasts of Flu RNA Vaccines in global, including the following market information:
Global Flu RNA Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Flu RNA Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Flu RNA Vaccines companies in 2021 (%)
The global Flu RNA Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Non-Replicating mRNA Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Flu RNA Vaccines include Sanofi Pasteur Inc., AstraZeneca, CSL Ltd., Abbott, GlaxoSmithKline Plc., Serum Institute of India Pvt. Ltd., Pfizer, BioNTech and F.Hoffman La Roche Ltd, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Flu RNA Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Flu RNA Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Flu RNA Vaccines Market Segment Percentages, by Type, 2021 (%)
Non-Replicating mRNA
In Vivo Self-Replicating mRNA
In Vitro Dendritic Cell Non-Replicating mRNA Vaccine
Others
Global Flu RNA Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Flu RNA Vaccines Market Segment Percentages, by Application, 2021 (%)
Hospitals
Vaccination Center
Specialized Clinics
Hospital Pharmacy
Others
Global Flu RNA Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Flu RNA Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Flu RNA Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Flu RNA Vaccines revenues share in global market, 2021 (%)
Key companies Flu RNA Vaccines sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Flu RNA Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi Pasteur Inc.
AstraZeneca
CSL Ltd.
Abbott
GlaxoSmithKline Plc.
Serum Institute of India Pvt. Ltd.
Pfizer
BioNTech
F.Hoffman La Roche Ltd
Novartis
Sinnovac Biotech Ltd
Moderna Therapeutics
CureVac
| Report Attributes |
Report Details |
| Report Title |
Flu RNA Vaccines Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
71 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Flu RNA Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Flu RNA Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Flu RNA Vaccines Overall Market Size
2.1 Global Flu RNA Vaccines Market Size: 2021 VS 2028
2.2 Global Flu RNA Vaccines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Flu RNA Vaccines Sales: 2017-2028
3 Company Landscape
3.1 Top Flu RNA Vaccines Players in Global Market
3.2 Top Global Flu RNA Vaccines Companies Ranked by Revenue
3.3 Global Flu RNA Vaccines Revenue by Companies
3.4 Global Flu RNA Vaccines Sales by Companies
3.5 Global Flu RNA Vaccines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Flu RNA Vaccines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Flu RNA Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Flu RNA Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Flu RNA Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Flu RNA Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Flu RNA Vaccines Market Size Markets, 2021 & 2028
4.1.2 Non-Replicating mRNA
4.1.3 In Vivo Self-Replicating mRNA
4.1.4 In Vitro Dendritic Cell Non-Replicating mRNA Vaccine
4.1.5 Others
4.2 By Type - Global Flu RNA Vaccines Revenue & Forecasts
4.2.1 By Type - Global Flu RNA Vaccines Revenue, 2017-2022
4.2.2 By Type - Global Flu RNA Vaccines Revenue, 2023-2028
4.2.3 By Type - Global Flu RNA Vaccines Revenue Market Share, 2017-2028
4.3 By Type - Global Flu RNA Vaccines Sales & Forecasts
4.3.1 By Type - Global Flu RNA Vaccines Sales, 2017-2022
4.3.2 By Type - Global Flu RNA Vaccines Sales, 2023-2028
4.3.3 By Type - Global Flu RNA Vaccines Sales Market Share, 2017-2028
4.4 By Type - Global Flu RNA Vaccines Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Flu RNA Vaccines Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Vaccination Center
5.1.4 Specialized Clinics
5.1.5 Hospital Pharmacy
5.1.6 Others
5.2 By Application - Global Flu RNA Vaccines Revenue & Forecasts
5.2.1 By Application - Global Flu RNA Vaccines Revenue, 2017-2022
5.2.2 By Application - Global Flu RNA Vaccines Revenue, 2023-2028
5.2.3 By Application - Global Flu RNA Vaccines Revenue Market Share, 2017-2028
5.3 By Application - Global Flu RNA Vaccines Sales & Forecasts
5.3.1 By Application - Global Flu RNA Vaccines Sales, 2017-2022
5.3.2 By Application - Global Flu RNA Vaccines Sales, 2023-2028
5.3.3 By Application - Global Flu RNA Vaccines Sales Market Share, 2017-2028
5.4 By Application - Global Flu RNA Vaccines Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Flu RNA Vaccines Market Size, 2021 & 2028
6.2 By Region - Global Flu RNA Vaccines Revenue & Forecasts
6.2.1 By Region - Global Flu RNA Vaccines Revenue, 2017-2022
6.2.2 By Region - Global Flu RNA Vaccines Revenue, 2023-2028
6.2.3 By Region - Global Flu RNA Vaccines Revenue Market Share, 2017-2028
6.3 By Region - Global Flu RNA Vaccines Sales & Forecasts
6.3.1 By Region - Global Flu RNA Vaccines Sales, 2017-2022
6.3.2 By Region - Global Flu RNA Vaccines Sales, 2023-2028
6.3.3 By Region - Global Flu RNA Vaccines Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Flu RNA Vaccines Revenue, 2017-2028
6.4.2 By Country - North America Flu RNA Vaccines Sales, 2017-2028
6.4.3 US Flu RNA Vaccines Market Size, 2017-2028
6.4.4 Canada Flu RNA Vaccines Market Size, 2017-2028
6.4.5 Mexico Flu RNA Vaccines Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Flu RNA Vaccines Revenue, 2017-2028
6.5.2 By Country - Europe Flu RNA Vaccines Sales, 2017-2028
6.5.3 Germany Flu RNA Vaccines Market Size, 2017-2028
6.5.4 France Flu RNA Vaccines Market Size, 2017-2028
6.5.5 U.K. Flu RNA Vaccines Market Size, 2017-2028
6.5.6 Italy Flu RNA Vaccines Market Size, 2017-2028
6.5.7 Russia Flu RNA Vaccines Market Size, 2017-2028
6.5.8 Nordic Countries Flu RNA Vaccines Market Size, 2017-2028
6.5.9 Benelux Flu RNA Vaccines Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Flu RNA Vaccines Revenue, 2017-2028
6.6.2 By Region - Asia Flu RNA Vaccines Sales, 2017-2028
6.6.3 China Flu RNA Vaccines Market Size, 2017-2028
6.6.4 Japan Flu RNA Vaccines Market Size, 2017-2028
6.6.5 South Korea Flu RNA Vaccines Market Size, 2017-2028
6.6.6 Southeast Asia Flu RNA Vaccines Market Size, 2017-2028
6.6.7 India Flu RNA Vaccines Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Flu RNA Vaccines Revenue, 2017-2028
6.7.2 By Country - South America Flu RNA Vaccines Sales, 2017-2028
6.7.3 Brazil Flu RNA Vaccines Market Size, 2017-2028
6.7.4 Argentina Flu RNA Vaccines Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Flu RNA Vaccines Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Flu RNA Vaccines Sales, 2017-2028
6.8.3 Turkey Flu RNA Vaccines Market Size, 2017-2028
6.8.4 Israel Flu RNA Vaccines Market Size, 2017-2028
6.8.5 Saudi Arabia Flu RNA Vaccines Market Size, 2017-2028
6.8.6 UAE Flu RNA Vaccines Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Sanofi Pasteur Inc.
7.1.1 Sanofi Pasteur Inc. Corporate Summary
7.1.2 Sanofi Pasteur Inc. Business Overview
7.1.3 Sanofi Pasteur Inc. Flu RNA Vaccines Major Product Offerings
7.1.4 Sanofi Pasteur Inc. Flu RNA Vaccines Sales and Revenue in Global (2017-2022)
7.1.5 Sanofi Pasteur Inc. Key News
7.2 AstraZeneca
7.2.1 AstraZeneca Corporate Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Flu RNA Vaccines Major Product Offerings
7.2.4 AstraZeneca Flu RNA Vaccines Sales and Revenue in Global (2017-2022)
7.2.5 AstraZeneca Key News
7.3 CSL Ltd.
7.3.1 CSL Ltd. Corporate Summary
7.3.2 CSL Ltd. Business Overview
7.3.3 CSL Ltd. Flu RNA Vaccines Major Product Offerings
7.3.4 CSL Ltd. Flu RNA Vaccines Sales and Revenue in Global (2017-2022)
7.3.5 CSL Ltd. Key News
7.4 Abbott
7.4.1 Abbott Corporate Summary
7.4.2 Abbott Business Overview
7.4.3 Abbott Flu RNA Vaccines Major Product Offerings
7.4.4 Abbott Flu RNA Vaccines Sales and Revenue in Global (2017-2022)
7.4.5 Abbott Key News
7.5 GlaxoSmithKline Plc.
7.5.1 GlaxoSmithKline Plc. Corporate Summary
7.5.2 GlaxoSmithKline Plc. Business Overview
7.5.3 GlaxoSmithKline Plc. Flu RNA Vaccines Major Product Offerings
7.5.4 GlaxoSmithKline Plc. Flu RNA Vaccines Sales and Revenue in Global (2017-2022)
7.5.5 GlaxoSmithKline Plc. Key News
7.6 Serum Institute of India Pvt. Ltd.
7.6.1 Serum Institute of India Pvt. Ltd. Corporate Summary
7.6.2 Serum Institute of India Pvt. Ltd. Business Overview
7.6.3 Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Major Product Offerings
7.6.4 Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Sales and Revenue in Global (2017-2022)
7.6.5 Serum Institute of India Pvt. Ltd. Key News
7.7 Pfizer
7.7.1 Pfizer Corporate Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Flu RNA Vaccines Major Product Offerings
7.7.4 Pfizer Flu RNA Vaccines Sales and Revenue in Global (2017-2022)
7.7.5 Pfizer Key News
7.8 BioNTech
7.8.1 BioNTech Corporate Summary
7.8.2 BioNTech Business Overview
7.8.3 BioNTech Flu RNA Vaccines Major Product Offerings
7.8.4 BioNTech Flu RNA Vaccines Sales and Revenue in Global (2017-2022)
7.8.5 BioNTech Key News
7.9 F.Hoffman La Roche Ltd
7.9.1 F.Hoffman La Roche Ltd Corporate Summary
7.9.2 F.Hoffman La Roche Ltd Business Overview
7.9.3 F.Hoffman La Roche Ltd Flu RNA Vaccines Major Product Offerings
7.9.4 F.Hoffman La Roche Ltd Flu RNA Vaccines Sales and Revenue in Global (2017-2022)
7.9.5 F.Hoffman La Roche Ltd Key News
7.10 Novartis
7.10.1 Novartis Corporate Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Flu RNA Vaccines Major Product Offerings
7.10.4 Novartis Flu RNA Vaccines Sales and Revenue in Global (2017-2022)
7.10.5 Novartis Key News
7.11 Sinnovac Biotech Ltd
7.11.1 Sinnovac Biotech Ltd Corporate Summary
7.11.2 Sinnovac Biotech Ltd Flu RNA Vaccines Business Overview
7.11.3 Sinnovac Biotech Ltd Flu RNA Vaccines Major Product Offerings
7.11.4 Sinnovac Biotech Ltd Flu RNA Vaccines Sales and Revenue in Global (2017-2022)
7.11.5 Sinnovac Biotech Ltd Key News
7.12 Moderna Therapeutics
7.12.1 Moderna Therapeutics Corporate Summary
7.12.2 Moderna Therapeutics Flu RNA Vaccines Business Overview
7.12.3 Moderna Therapeutics Flu RNA Vaccines Major Product Offerings
7.12.4 Moderna Therapeutics Flu RNA Vaccines Sales and Revenue in Global (2017-2022)
7.12.5 Moderna Therapeutics Key News
7.13 CureVac
7.13.1 CureVac Corporate Summary
7.13.2 CureVac Flu RNA Vaccines Business Overview
7.13.3 CureVac Flu RNA Vaccines Major Product Offerings
7.13.4 CureVac Flu RNA Vaccines Sales and Revenue in Global (2017-2022)
7.13.5 CureVac Key News
8 Global Flu RNA Vaccines Production Capacity, Analysis
8.1 Global Flu RNA Vaccines Production Capacity, 2017-2028
8.2 Flu RNA Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Flu RNA Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Flu RNA Vaccines Supply Chain Analysis
10.1 Flu RNA Vaccines Industry Value Chain
10.2 Flu RNA Vaccines Upstream Market
10.3 Flu RNA Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Flu RNA Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Flu RNA Vaccines in Global Market
Table 2. Top Flu RNA Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Flu RNA Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Flu RNA Vaccines Revenue Share by Companies, 2017-2022
Table 5. Global Flu RNA Vaccines Sales by Companies, (K Units), 2017-2022
Table 6. Global Flu RNA Vaccines Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Flu RNA Vaccines Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Flu RNA Vaccines Product Type
Table 9. List of Global Tier 1 Flu RNA Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Flu RNA Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Flu RNA Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Flu RNA Vaccines Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Flu RNA Vaccines Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Flu RNA Vaccines Sales (K Units), 2017-2022
Table 15. By Type - Global Flu RNA Vaccines Sales (K Units), 2023-2028
Table 16. By Application ? Global Flu RNA Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Flu RNA Vaccines Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Flu RNA Vaccines Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Flu RNA Vaccines Sales (K Units), 2017-2022
Table 20. By Application - Global Flu RNA Vaccines Sales (K Units), 2023-2028
Table 21. By Region ? Global Flu RNA Vaccines Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Flu RNA Vaccines Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Flu RNA Vaccines Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Flu RNA Vaccines Sales (K Units), 2017-2022
Table 25. By Region - Global Flu RNA Vaccines Sales (K Units), 2023-2028
Table 26. By Country - North America Flu RNA Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Flu RNA Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Flu RNA Vaccines Sales, (K Units), 2017-2022
Table 29. By Country - North America Flu RNA Vaccines Sales, (K Units), 2023-2028
Table 30. By Country - Europe Flu RNA Vaccines Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Flu RNA Vaccines Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Flu RNA Vaccines Sales, (K Units), 2017-2022
Table 33. By Country - Europe Flu RNA Vaccines Sales, (K Units), 2023-2028
Table 34. By Region - Asia Flu RNA Vaccines Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Flu RNA Vaccines Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Flu RNA Vaccines Sales, (K Units), 2017-2022
Table 37. By Region - Asia Flu RNA Vaccines Sales, (K Units), 2023-2028
Table 38. By Country - South America Flu RNA Vaccines Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Flu RNA Vaccines Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Flu RNA Vaccines Sales, (K Units), 2017-2022
Table 41. By Country - South America Flu RNA Vaccines Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Flu RNA Vaccines Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Flu RNA Vaccines Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Flu RNA Vaccines Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Flu RNA Vaccines Sales, (K Units), 2023-2028
Table 46. Sanofi Pasteur Inc. Corporate Summary
Table 47. Sanofi Pasteur Inc. Flu RNA Vaccines Product Offerings
Table 48. Sanofi Pasteur Inc. Flu RNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. AstraZeneca Corporate Summary
Table 50. AstraZeneca Flu RNA Vaccines Product Offerings
Table 51. AstraZeneca Flu RNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. CSL Ltd. Corporate Summary
Table 53. CSL Ltd. Flu RNA Vaccines Product Offerings
Table 54. CSL Ltd. Flu RNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Abbott Corporate Summary
Table 56. Abbott Flu RNA Vaccines Product Offerings
Table 57. Abbott Flu RNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. GlaxoSmithKline Plc. Corporate Summary
Table 59. GlaxoSmithKline Plc. Flu RNA Vaccines Product Offerings
Table 60. GlaxoSmithKline Plc. Flu RNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Serum Institute of India Pvt. Ltd. Corporate Summary
Table 62. Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Product Offerings
Table 63. Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Pfizer Corporate Summary
Table 65. Pfizer Flu RNA Vaccines Product Offerings
Table 66. Pfizer Flu RNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. BioNTech Corporate Summary
Table 68. BioNTech Flu RNA Vaccines Product Offerings
Table 69. BioNTech Flu RNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. F.Hoffman La Roche Ltd Corporate Summary
Table 71. F.Hoffman La Roche Ltd Flu RNA Vaccines Product Offerings
Table 72. F.Hoffman La Roche Ltd Flu RNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Novartis Corporate Summary
Table 74. Novartis Flu RNA Vaccines Product Offerings
Table 75. Novartis Flu RNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Sinnovac Biotech Ltd Corporate Summary
Table 77. Sinnovac Biotech Ltd Flu RNA Vaccines Product Offerings
Table 78. Sinnovac Biotech Ltd Flu RNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Moderna Therapeutics Corporate Summary
Table 80. Moderna Therapeutics Flu RNA Vaccines Product Offerings
Table 81. Moderna Therapeutics Flu RNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. CureVac Corporate Summary
Table 83. CureVac Flu RNA Vaccines Product Offerings
Table 84. CureVac Flu RNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Flu RNA Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 86. Global Flu RNA Vaccines Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Flu RNA Vaccines Production by Region, 2017-2022 (K Units)
Table 88. Global Flu RNA Vaccines Production by Region, 2023-2028 (K Units)
Table 89. Flu RNA Vaccines Market Opportunities & Trends in Global Market
Table 90. Flu RNA Vaccines Market Drivers in Global Market
Table 91. Flu RNA Vaccines Market Restraints in Global Market
Table 92. Flu RNA Vaccines Raw Materials
Table 93. Flu RNA Vaccines Raw Materials Suppliers in Global Market
Table 94. Typical Flu RNA Vaccines Downstream
Table 95. Flu RNA Vaccines Downstream Clients in Global Market
Table 96. Flu RNA Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Flu RNA Vaccines Segment by Type
Figure 2. Flu RNA Vaccines Segment by Application
Figure 3. Global Flu RNA Vaccines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Flu RNA Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Flu RNA Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. Flu RNA Vaccines Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Flu RNA Vaccines Revenue in 2021
Figure 9. By Type - Global Flu RNA Vaccines Sales Market Share, 2017-2028
Figure 10. By Type - Global Flu RNA Vaccines Revenue Market Share, 2017-2028
Figure 11. By Type - Global Flu RNA Vaccines Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Flu RNA Vaccines Sales Market Share, 2017-2028
Figure 13. By Application - Global Flu RNA Vaccines Revenue Market Share, 2017-2028
Figure 14. By Application - Global Flu RNA Vaccines Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Flu RNA Vaccines Sales Market Share, 2017-2028
Figure 16. By Region - Global Flu RNA Vaccines Revenue Market Share, 2017-2028
Figure 17. By Country - North America Flu RNA Vaccines Revenue Market Share, 2017-2028
Figure 18. By Country - North America Flu RNA Vaccines Sales Market Share, 2017-2028
Figure 19. US Flu RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Flu RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Flu RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Flu RNA Vaccines Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Flu RNA Vaccines Sales Market Share, 2017-2028
Figure 24. Germany Flu RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. France Flu RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Flu RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Flu RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Flu RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Flu RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Flu RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Flu RNA Vaccines Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Flu RNA Vaccines Sales Market Share, 2017-2028
Figure 33. China Flu RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Flu RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Flu RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Flu RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. India Flu RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Flu RNA Vaccines Revenue Market Share, 2017-2028
Figure 39. By Country - South America Flu RNA Vaccines Sales Market Share, 2017-2028
Figure 40. Brazil Flu RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Flu RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Flu RNA Vaccines Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Flu RNA Vaccines Sales Market Share, 2017-2028
Figure 44. Turkey Flu RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Flu RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Flu RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Flu RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 48. Global Flu RNA Vaccines Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Flu RNA Vaccines by Region, 2021 VS 2028
Figure 50. Flu RNA Vaccines Industry Value Chain
Figure 51. Marketing Channels
